Speaker illustration

Professor Eliano Pio Navarese

Clinical and Experimental Cardiology, Sassari (Italy)

Prof Navarese is currently associate Professor and director of Research at the Cardiovascular Institute, Nicolaus Copernicus University, Poland and adjunct professor at University of Alberta, Canada. He is Director of SIRIO MEDICINE (www.siriomedicine.com) an academic international research network. His expertise is in the fields of interventional cardiology, coronary artery disease, antithrombotics, lipid-lowering therapies, cardiovascular pharmacotherapy, clinical trials and evidence-based medicine.

Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session type: Advances in Science

Thumbnail

Do we need PCSK9 inhibitors in post-MI patients?

Event: ESC Congress 2017

Topic: Drug therapy

Session type: Debate Session

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb